(Q38207274)

English

Ipilimumab in patients with cancer and the management of dermatologic adverse events

scientific article published on 24 April 2014

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

31 August 2017

Ipilimumab in patients with cancer and the management of dermatologic adverse events (English)

1 reference

stated in

Europe PubMed Central

31 August 2017

0 references

Gil Yosipovitch

3

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

Katharina C Kähler

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

Klaus J Busam

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

Axel Hauschild

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

language of work or name

English

0 references

publication date

24 April 2014

1 reference

stated in

Europe PubMed Central

31 August 2017

Journal of the American Academy of Dermatology

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

volume

71

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

page(s)

161-169

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 June 2020

Identifiers

DOI

10.1016/J.JAAD.2014.02.035

1 reference

stated in

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

Europe PubMed Central

PubMed ID

24767731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24767731%20AND%20SRC:MED&resulttype=core&format=json

(Q38207274)

Ipilimumab in patients with cancer and the management of dermatologic adverse events

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)